It offers M-SERIES family of products to screen, monitor, and diagnose medical conditions and for drug discovery and development.
It also offers BioVeris Detection System and Reagents to detect bacteria, viruses, and toxins; Test Panel for BioVeris Detection System to detect food and beverage contaminants; and Picolumi to screen, monitor, and diagnose medical conditions; as well as offers Cell Culture Reagents for biological research.
The company’s products are designed for diagnostics markets, that include clinical diagnostics, including the testing of patient samples to measure the presence of disease and monitor medical conditions; and nonclinical diagnostics for the biodefense, life science, and industrial markets.
BioVeris offers its products in the United States and Europe.
The company was organized as IGEN Integrated Healthcare, LLC, a Delaware limited liability company, in June 2003, and converted into BioVeris Corporation, a Delaware corporation, in September 2003.
The company is headquartered in Gaithersburg, Maryland.
